Christine Siu
CIK: 0001743029
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GLUE
Monte Rosa Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Siu Christine
Siu Christine (SEC CIK 0001743029) files insider reports with the SEC as Director of Monte Rosa Therapeutics, Inc. (GLUE).
Signal8 holds 2 ownership filings by Siu Christine, all Form 4s, filed between Jun 16, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 13, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Siu Christine's filings is in BOSTON, MA.
Recent filings by Siu Christine
Other insiders filing for Monte Rosa Therapeutics, Inc. (GLUE)
- Bowen Matthew, Principal Accounting Officer
- Warmuth Markus, President & CEO
- Champoux Jennifer, Chief Operating Officer
- Townson Sharon, Chief Scientific Officer
- Behbahani Ali, Director
- Janku Filip, Chief Medical Officer